JENSCARE-B (9877.HK)

Jenscare, with innovative TTVR, releases 2024H1 interim results

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, released interim results for 2024H1 ended June 30, 2024.